Our mission is to enable long-term investment in innovative companies across the UK led by ambitious entrepreneurs.

The UK provides a fertile ground for innovation to thrive, but a lack of access to patient capital continues to hold back some UK companies from scaling up and fulfilling their commercial potential. British Patient Capital will enable greater availability of this type of long-term finance and will help build the UK’s innovation economy.

British Patient Capital will be developed as a separate subsidiary of the British Business Bank and builds on a successful 10-year heritage of investing £1bn into UK venture and growth capital.


British Patient Capital

Domain Not Resolving

AJAX Libraries API

Amazon London Region

Director, Life Sciences – BPC Direct and Co-Investments

Carmine Circelli

Investment Director

Michael Laycock

Robert Greenwood

Director, Direct Investments

Tom Haywood

Senior Investment Manager

Anu Adebajo

Investment Manager

Chloe Hall

Investment Manager (Life Sciences)

Emma Johnson

Senior Investment Manager, Life Sciences

Sajni Chotai

Senior Communications Manager

Sami Dodangeh

Senior Communications/Institutional Relations Lead British Patient Capital

James Burnham

Alexandra Woodman

Investment Analyst

George Mills

Catherine Lewis La Torre

Chief Executive Officer

Ian Connatty

Managing Director, Funds

Max Middleton

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Investors Active in Oxfordshire

Late Stage Venture Investors with Investments in Manchester, Manchester

Investors Active in Oxford, Oxfordshire

Venture Capital Investors (Top 10K)

British Patient Capital invests in a diversified portfolio of best-in-class venture and growth capital funds and start ups, capturing value through financing the growth of innovative companies. We invest on a commercial basis to deliver competitive returns and manage risk.

As well as providing our own funding we work to encourage more investors to make allocations to this asset class by demonstrating that a long-term patient capital investment strategy can produce commercially attractive returns.

Once we’ve established a strong record, and have proved the value of the asset class, we intend to privatise British Patient Capital at an appropriate time in the future.

Sheffield

United Kingdom

Europe

British Patient Capital invests in Purespring Therapeutics’ £80m financing round

Form3 bags $60m Series C extension with new investor British Patient Capital

British Patient Capital pledges £70m to Balderton funds

Kennet closes €266m software fund with British Patient Capital backing

India

Asia

Pakistan

aPriori Capital Partners LP is a competitor of British Patient Capital, focusing on long-term investment in innovative companies.

aPriori Capital Partners LP

Connection Capital LLP is a competitor of British Patient Capital, specializing in providing patient capital to innovative businesses.

Connection Capital LLP

Noda Capital Ltd is a competitor of British Patient Capital, offering long-term investment solutions to high-growth potential companies.

Noda Capital Ltd

British Patient Capital is a subsidiary of the government-owned British Business Bank plc. It operates as an impact investor, providing patient capital to high-growth potential companies in the UK, with the aim of enabling them to scale and succeed on a global stage. The firm invests across a range of sectors, focusing on innovative businesses with significant growth prospects.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 13, 2024 6:14 PM	cc3b5e6e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	8150b6f5
crunchbase profile	general	Nov 22, 2024 8:44 AM	d4145800
li profile	general	May 13, 2024 6:14 PM	ee73262e
translate crunchbase fundingrounds	general	Nov 22, 2024 10:56 AM	a8c754e4
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

UK:CO:BRITISHPATIENTCAPITAL

British Patient Capital